AU2002221840A1 - Human adenylate cyclase - Google Patents

Human adenylate cyclase

Info

Publication number
AU2002221840A1
AU2002221840A1 AU2002221840A AU2184002A AU2002221840A1 AU 2002221840 A1 AU2002221840 A1 AU 2002221840A1 AU 2002221840 A AU2002221840 A AU 2002221840A AU 2184002 A AU2184002 A AU 2184002A AU 2002221840 A1 AU2002221840 A1 AU 2002221840A1
Authority
AU
Australia
Prior art keywords
adenylate cyclase
human adenylate
reagents
limited
disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002221840A
Inventor
Zhimin Zhu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of AU2002221840A1 publication Critical patent/AU2002221840A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y406/00—Phosphorus-oxygen lyases (4.6)
    • C12Y406/01—Phosphorus-oxygen lyases (4.6.1)
    • C12Y406/01001—Aodenylate cyclase (4.6.1.1)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Bidet-Like Cleaning Device And Other Flush Toilet Accessories (AREA)
  • External Artificial Organs (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Reagents which regulate human adenylate cyclase and reagents which bind to human adenylate cyclase gene products can play a role in preventing, ameliorating, or correcting dysfunctions or diseases including, but not limited to, peripheral and central nervous system disorders, disorders of the genito-urinary system including but not limited to benign prostatic hyperplasia and urinary incontinence, obesity, COPD and diabetes.
AU2002221840A 2000-11-13 2001-11-12 Human adenylate cyclase Abandoned AU2002221840A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US24700500P 2000-11-13 2000-11-13
US60/247,005 2000-11-13
US26718101P 2001-02-08 2001-02-08
US60/267,181 2001-02-08
PCT/EP2001/013060 WO2002038747A2 (en) 2000-11-13 2001-11-12 Human adenylate cyclase

Publications (1)

Publication Number Publication Date
AU2002221840A1 true AU2002221840A1 (en) 2002-05-21

Family

ID=26938388

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002221840A Abandoned AU2002221840A1 (en) 2000-11-13 2001-11-12 Human adenylate cyclase

Country Status (7)

Country Link
US (1) US7205135B2 (en)
EP (1) EP1335973B1 (en)
AT (1) ATE421580T1 (en)
AU (1) AU2002221840A1 (en)
DE (1) DE60137528D1 (en)
ES (1) ES2319104T3 (en)
WO (1) WO2002038747A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040020993A1 (en) * 2001-12-28 2004-02-05 Green Larry R. Method for luminescent identification and calibration
US20040060987A1 (en) * 2002-05-07 2004-04-01 Green Larry R. Digital image analysis method for enhanced and optimized signals in fluorophore detection
AU2003238440A1 (en) * 2002-05-31 2003-12-19 Bayer Aktiengesellschaft Regulation of human adenylate cyclase, type ii
CN114982718B (en) * 2022-06-30 2023-07-21 滨州医学院 Mouse systemic obesity model caused by gene defect and construction method thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6107076A (en) 1995-10-04 2000-08-22 Board Of Regents, The University Of Texas System Soluble mammalian adenylyl cyclase and uses therefor
WO2001044453A1 (en) * 1999-12-14 2001-06-21 Millennium Pharmaceuticals, Inc. 25678, a novel human adenylate cyclase

Also Published As

Publication number Publication date
ES2319104T3 (en) 2009-05-04
US20040063174A1 (en) 2004-04-01
DE60137528D1 (en) 2009-03-12
EP1335973A2 (en) 2003-08-20
WO2002038747A2 (en) 2002-05-16
EP1335973B1 (en) 2009-01-21
ATE421580T1 (en) 2009-02-15
US7205135B2 (en) 2007-04-17
WO2002038747A3 (en) 2003-02-27

Similar Documents

Publication Publication Date Title
WO2002004610A3 (en) Regulation of human dipeptidyl-peptidase iv-like enzyme
WO2002036783A3 (en) Regulation of human histone deacetylase
AU2002221840A1 (en) Human adenylate cyclase
WO2002020731A3 (en) Regulation of human protein disulfide isomerase-like enzyme
WO2002040538A8 (en) Regulation of human nmda receptor
WO2002072824A3 (en) Human transient receptor potential channel protein.
WO2002036629A3 (en) Regulation of human serotonin receptor precursor
WO2003087158A3 (en) Regulation of human transient receptor potential channel
WO2001077149A3 (en) Regulation of human cyslt2-like gpcr protein
WO2002036613A3 (en) Regulation of human patched-like protein
WO2002055712A3 (en) Regulation of human alanine aminotransferase
WO2002053749A3 (en) Regulation of human serine-threonine protein kinase
WO2001070812A3 (en) Regulation of human histamine h2-like g protein-coupled receptor
WO2002033056A3 (en) Regulation of human serine-threonine protein kinase
WO2002092799A3 (en) Regulation of human steroid 5-alpha reductase-like protein
WO2002033097A3 (en) Regulation of human sulfotransferase
WO2002024878A3 (en) Human e3 ubiquitin protein ligase-like enzyme
WO2002000703A3 (en) REGULATION OF HUMAN GLUTAMYL-tRNA (Gln) AMIDOTRANSFERASE-LIKE ENZYME
WO2002030969A3 (en) Regulation of human carboxylesterase-like enzyme
WO2002052016A3 (en) Regulation of human protein l-isoaspartate o-methyltransferase-like enzyme
AU2002315253A1 (en) Regulation of human protein kinase-like protein
WO2003027225A3 (en) Regulation of human steroid 5-alpha reductase
WO2002018552A8 (en) Regulation of human aminotransferase-like enzyme
WO2002018567A3 (en) Regulation of human aminotransferase-like enzyme
WO2002026945A3 (en) Regulation of human aminotransferase-like enzyme